Works matching IS 00302414 AND DT 2018 AND VI 94

Results: 63
    1
    2
    3
    4
    5
    6
    7
    8
    9

    Prelims.

    Published in:
    2018
    Publication type:
    Table of Contents
    10

    Front & Back Matter.

    Published in:
    Oncology, 2018, v. 94, n. 6, p. N.PAG, doi. 10.1159/000490431
    Publication type:
    Article
    11

    Contents Vol. 94, 2018.

    Published in:
    Oncology, 2018, v. 94, n. 6, p. I, doi. 10.1159/000489617
    Publication type:
    Article
    12
    13

    Epidermal Growth Factor Receptor Regulation of Ewing Sarcoma Cell Function.

    Published in:
    Oncology, 2018, v. 94, n. 6, p. 383, doi. 10.1159/000487143
    By:
    • Kersting, Nathália ;
    • Kunzler Souza, Bárbara ;
    • Araujo Vieira, Igor ;
    • Pereira dos Santos, Rafael ;
    • Brufatto Olguins, Danielly ;
    • José Gregianin, Lauro ;
    • Tesainer Brunetto, André ;
    • Lunardi Brunetto, Algemir ;
    • Roesler, Rafael;
    • Brunetto de Farias, Caroline;
    • Schwartsmann, Gilberto
    Publication type:
    Article
    14
    15
    16
    17

    Actionable Locoregional Relapses after Therapy of Localized Esophageal Cancer: Insights from a Large Cohort.

    Published in:
    Oncology, 2018, v. 94, n. 6, p. 345, doi. 10.1159/000486720
    By:
    • Elimova, Elena;
    • Wang, Xuemei;
    • Qiao, Wei;
    • Sudo, Kazuki;
    • Wadhwa, Roopma;
    • Shiozaki, Hironori;
    • Shimodaira, Yusuke;
    • Planjery, Venkatram;
    • Charalampakis, Nikolaos;
    • Lee, Jeffrey H.;
    • Weston, Brian R.;
    • Bhutani, Manoop S.;
    • Komaki, Ritsuko;
    • Rice, David C.;
    • Swisher, Stephen G.;
    • Blum, Mariela A.;
    • Rogers, Jane E.;
    • Skinner, Heath D.;
    • Maru, Dipen M.;
    • Hofstetter, Wayne L.
    Publication type:
    Article
    18
    19

    A Randomized Phase II Open-Label Multi-Institution Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients with Advanced Hepatocellular Carcinoma.

    Published in:
    Oncology, 2018, v. 94, n. 6, p. 329, doi. 10.1159/000485384
    By:
    • Thomas, Melanie B.;
    • Garrett-Mayer, Elizabeth;
    • Anis, Munazza;
    • Anderton, Kate;
    • Bentz, Tricia;
    • Edwards, Andie;
    • Brisendine, Alan;
    • Weiss, Geoffrey;
    • Siegel, Abby B.;
    • Bendell, Johanna;
    • Baron, Ari;
    • Duddalwar, Vinay;
    • El-Khoueiry, Anthony
    Publication type:
    Article
    20
    21
    22
    23

    Front & Back Matter.

    Published in:
    Oncology, 2018, v. 94, n. 4, p. 1, doi. 10.1159/000488545
    Publication type:
    Article
    24
    25
    26
    27
    28

    Real-World Treatment Patterns, Survival, and Prediction of CNS Progression in ALK-Positive Non-Small-Cell Lung Cancer Patients Treated with First-Line Crizotinib in Latin America Oncology Practices.

    Published in:
    Oncology, 2018, v. 94, n. 5, p. 297, doi. 10.1159/000486862
    By:
    • Martín, Claudio;
    • Cardona, Andrés F.;
    • Zatarain-Barrón, Zyanya Lucia;
    • Ruiz-Patiño, Alejandro;
    • Castillo, Omar;
    • Oblitas, George;
    • Corrales, Luis;
    • Lupinacci, Lorena;
    • Pérez, María Angelina;
    • Rojas, Leonardo;
    • González, Lisde;
    • Chirinos, Luis;
    • Ortíz, Carlos;
    • Lema, Mauricio;
    • Vargas, Carlos;
    • Puparelli, Carmen;
    • Carranza, Hernán;
    • Otero, Jorge;
    • Arrieta, Oscar
    Publication type:
    Article
    29
    30
    31
    32
    33

    Prophylactic Effect of Dexamethasone on Regorafenib-Related Fatigue and/or Malaise: A Randomized, Placebo-Controlled, Double-Blind Clinical Study in Patients with Unresectable Metastatic Colorectal Cancer (KSCC1402/HGCSG1402).

    Published in:
    Oncology, 2018, v. 94, n. 5, p. 289, doi. 10.1159/000486624
    By:
    • Tanioka, Hiroaki;
    • Miyamoto, Yuji;
    • Tsuji, Akihito;
    • Asayama, Masako;
    • Shiraishi, Takeshi;
    • Yuki, Satoshi;
    • Kotaka, Masahito;
    • Makiyama, Akitaka;
    • Shimokawa, Mototsugu;
    • Shimose, Takayuki;
    • Masuda, Satohiro;
    • Yamaguchi, Takuhiro;
    • Komatsu, Yoshito;
    • Saeki, Hiroshi;
    • Emi, Yasunori;
    • Baba, Hideo;
    • Oki, Eiji;
    • Maehara, Yoshihiko
    Publication type:
    Article
    34

    Characteristics of Hepatocellular Carcinoma Aggressiveness Factors in Turkish Patients.

    Published in:
    Oncology, 2018, v. 94, n. 2, p. 116, doi. 10.1159/000484564
    By:
    • Akkiz, Hikmet;
    • Carr, Brian I.;
    • Yalçın K., Kendal;
    • Guerra, Vito;
    • Kuran, Sedef;
    • Altıntaş, Engin;
    • Üsküdar, Oğuz;
    • Karaoğullarından, Ümit;
    • Özakyol, Ayşegül;
    • Tokmak, Salih;
    • Yücesoy, Mehmet;
    • Bahçeci, Halil İbrahim;
    • Ülkü, Abdulalh;
    • Akçam, Tolga;
    • Yalçın Polat, Kamil;
    • Ekinci, Nazım;
    • Şimşek, Halis;
    • Örmeci, Necati;
    • Sonsuz, Abdulalh;
    • Demir, Mehmet
    Publication type:
    Article
    35
    36

    Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy Combined with Radiotherapy and Sorafenib for Advanced Hepatocellular Carcinoma Patients with Major Portal Vein Tumor Thrombosis.

    Published in:
    Oncology, 2018, v. 94, n. 4, p. 215, doi. 10.1159/000486483
    By:
    • Kodama, Kenichiro;
    • Kawaoka, Tomokazu;
    • Aikata, Hiroshi;
    • Uchikawa, Shinsuke;
    • Nishida, Yuno;
    • Inagaki, Yuki;
    • Hatooka, Masahiro;
    • Morio, Kei;
    • Nakahara, Takashi;
    • Murakami, Eisuke;
    • Tsuge, Masataka;
    • Hiramatsu, Akira;
    • Imamura, Michio;
    • Kawakami, Yoshiiku;
    • Masaki, Keiichi;
    • Honda, Yoji;
    • Mori, Nami;
    • Takaki, Shintaro;
    • Tsuji, Keiji;
    • Kohno, Hirotaka
    Publication type:
    Article
    37
    38
    39

    Efficacy of Platinum-Based Chemotherapy for Relapsed Small-Cell Lung Cancer after Amrubicin Monotherapy in Elderly Patients and Patients with Poor Performance Status.

    Published in:
    Oncology, 2018, v. 94, n. 4, p. 207, doi. 10.1159/000486038
    By:
    • Igawa, Satoshi;
    • Shirasawa, Masayuki;
    • Fukui, Tomoya;
    • Nishinarita, Noriko;
    • Sone, Hideyuki;
    • Ozawa, Takahiro;
    • Sugita, Keisuke;
    • Okuma, Yuriko;
    • Kurahayashi, Shintaro;
    • Ono, Taihei;
    • Sugimoto, Ai;
    • Mitsufuji, Hisashi;
    • Kubota, Masaru;
    • Katagiri, Masato;
    • Sasaki, Jiichiro;
    • Naoki, Katsuhiko
    Publication type:
    Article
    40
    41
    42
    43

    Erratum.

    Published in:
    2018
    Publication type:
    Correction Notice
    44
    45
    46
    47
    48
    49
    50

    Clinical Efficacy and Safety of First-Line Dasatinib Therapy and the Relevance of Velocity of BCR-ABL1 Transcript Decline for Achievement of Molecular Responses in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Report from the Juntendo Yamanashi Cooperative Study Group

    Published in:
    Oncology, 2018, v. 94, n. 2, p. 85, doi. 10.1159/000481945
    By:
    • Takaku, Tomoiku;
    • Iriyama, Noriyoshi;
    • Mitsumori, Toru;
    • Sato, Eriko;
    • Gotoh, Akihiko;
    • Kirito, Keita;
    • Noguchi, Masaaki;
    • Koike, Michiaki;
    • Sakamoto, Junichi;
    • Oba, Koji;
    • Komatsu, Norio
    Publication type:
    Article